ABCC11 and breast cancer: To confirm that both ABCB1 and ABCC11 were able to confer resistance to eribulin in breast cancer cells, we tested whether transient overexpression of ABCB1 or ABCC11 would alter the sensitivity to eribulin in HEK293T cells.